J&J rethinking Guidant buyout
2nd Nov 2005, 18:29 GMT
Johnson & Johnson said Wednesday that recent Guidant defibrillator recalls are "serious" and it may scrap plans to buy the device firm.
J&J rethinking Guidant buyout related news:
- FTC Sets Guidelines for J&J's Guidant Buy — E-Commerce Times
- Johnson & Johnson May Cancel Guidant Buyout — WXII12.com - Money
- J&J Presses Guidant on Takeover Price — WSJ.com: What's News US
- JVamp;J threatens to drop its deal for Guidant — Business - International Herald Tribune
- J&J Receives FTC Clearance of Proposed Acquisition of Guidant Corp and Provides Update on Transaction in Light of Guidant Recall Events — Radiology News from StratCenter.com
- DLT Solutions managers lead buyout — Washington Technology
- Johnson & Johnson says it might not complete Guidant deal — Breaking Business (AP)
- Johnson & Johnson stellt Übernahme von Guidant in Frage — Finanztreff.de / TOPTHEMEN
- J&J says may not close Guidant deal — Financial News News from StratCenter.com
- J&J may cancel $25.4 billion Guidant acquisition — SacBee -- 24-Hour News: Top Stories
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries